TY - JOUR
T1 - Prognostic factors in pediatric Hodgkin disease
AU - Schwartz, Cindy L.
N1 - Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2003/11
Y1 - 2003/11
N2 - The sensitivity of pediatric Hodgkin disease to radiation and chemotherapy has resulted in cure for most children and adolescents who have been diagnosed in the past three decades. Identification of prognostic factors in clinical trials has allowed for tailoring of therapeutic approaches to improve outcome in sequential trials. Tumor burden, symptoms, clinical features, pathology, response to therapy, biology, and host factors are reviewed in this context. New developments should be directed toward identification of factors associated with biologic mechanisms of disease to facilitate the development of biologically targeted therapies that will be more efficacious and less toxic.
AB - The sensitivity of pediatric Hodgkin disease to radiation and chemotherapy has resulted in cure for most children and adolescents who have been diagnosed in the past three decades. Identification of prognostic factors in clinical trials has allowed for tailoring of therapeutic approaches to improve outcome in sequential trials. Tumor burden, symptoms, clinical features, pathology, response to therapy, biology, and host factors are reviewed in this context. New developments should be directed toward identification of factors associated with biologic mechanisms of disease to facilitate the development of biologically targeted therapies that will be more efficacious and less toxic.
UR - http://www.scopus.com/inward/record.url?scp=2442482680&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2442482680&partnerID=8YFLogxK
U2 - 10.1007/s11912-003-0011-0
DO - 10.1007/s11912-003-0011-0
M3 - Review article
C2 - 14521809
AN - SCOPUS:2442482680
SN - 1523-3790
VL - 5
SP - 498
EP - 504
JO - Current oncology reports
JF - Current oncology reports
IS - 6
ER -